Skip to main content
Top
Published in: International Urology and Nephrology 7/2019

01-07-2019 | Nephrology - Original Paper

Association of serum IL-18 with protein-energy wasting in end-stage renal disease patients on haemodialysis

Authors: Xiao Bi, Mingzi Chu, Honglan Ai, Chun Hu, Wei Ding

Published in: International Urology and Nephrology | Issue 7/2019

Login to get access

Abstract

Purpose

Protein-energy wasting (PEW) is highly prevalent in end-stage renal disease (ESRD) patients with inflammation who are on haemodialysis treatment. Interleukin-18 (IL-18) is an important pro-inflammatory cytokine that is significantly elevated in ESRD patients. However, the relationship between PEW and IL-18 is unclear. We therefore performed a cross-sectional study on 100 ESRD patients undergoing haemodialysis to clarify this.

Methods

PEW was defined according to the diagnostic criteria of the International Society of Renal Nutrition and Metabolism. Inflammation was assessed based on the serum levels of C-reactive protein (CRP), interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α) and IL-18. We analysed the association between PEW and IL-18 by using logistic analysis and linear regression after adjustment for basic characteristics, comorbidities and laboratory findings.

Results

Among the 100 haemodialysis patients who were recruited, 56 had PEW. Even though there was no difference between the PEW group and non-PEW group with regard to disease causes, age, gender, cholesterol, ferritin, and haemoglobin, the levels of inflammation indicators such as CRP, IL-6, TNF-α and IL-1β were significantly higher in the PEW group. Moreover, IL-18 was found to contribute to PEW, but was negatively correlated with pre-albumin after adjustment for possible confounding factors.

Conclusions

Thus, the findings indicate that IL-18 is associated with PEW in ESRD patients on haemodialysis, which suggests that IL-18 may be involved in the pathogenesis of PEW in this setting.
Literature
1.
go back to reference Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73(4):391–398CrossRefPubMed Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73(4):391–398CrossRefPubMed
2.
go back to reference Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C (2013) International society of renal nutrition and metabolism Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the international society of renal nutrition and metabolism. Kidney Int 84(6):1096–1107CrossRefPubMed Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C (2013) International society of renal nutrition and metabolism Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the international society of renal nutrition and metabolism. Kidney Int 84(6):1096–1107CrossRefPubMed
3.
go back to reference Miyamoto T, Carrero JJ, Stenvinkel P (2011) Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 20(6):662–668CrossRefPubMed Miyamoto T, Carrero JJ, Stenvinkel P (2011) Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 20(6):662–668CrossRefPubMed
4.
go back to reference Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526–1533CrossRefPubMedPubMedCentral Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526–1533CrossRefPubMedPubMedCentral
5.
go back to reference Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K (2015) Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care 18(3):254–262CrossRefPubMedPubMedCentral Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K (2015) Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care 18(3):254–262CrossRefPubMedPubMedCentral
7.
go back to reference Tummalapalli L, Nadkarni GN, Coca SG (2016) Biomarkers for predicting outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 25(6):480–486CrossRefPubMed Tummalapalli L, Nadkarni GN, Coca SG (2016) Biomarkers for predicting outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 25(6):480–486CrossRefPubMed
8.
go back to reference Ding W, Guo H, Xu C, Wang B, Zhang M, Ding F (2016) Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury. Oncotarget 7(14):17479–17491CrossRefPubMedPubMedCentral Ding W, Guo H, Xu C, Wang B, Zhang M, Ding F (2016) Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury. Oncotarget 7(14):17479–17491CrossRefPubMedPubMedCentral
9.
go back to reference Artlett CM, Thacker JD (2015) Molecular activation of the NLRP3 Inflammasome in fibrosis: common threads linking divergent fibrogenic diseases. Antioxid Redox Signal 22(13):1162–1175CrossRefPubMed Artlett CM, Thacker JD (2015) Molecular activation of the NLRP3 Inflammasome in fibrosis: common threads linking divergent fibrogenic diseases. Antioxid Redox Signal 22(13):1162–1175CrossRefPubMed
10.
go back to reference Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, Muruve DA (2010) The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 21(10):1732–1744CrossRefPubMedPubMedCentral Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, Muruve DA (2010) The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 21(10):1732–1744CrossRefPubMedPubMedCentral
11.
go back to reference Murphy AJ, Kraakman MJ, Kammoun HL, Dragoljevic D, Lee MK, Lawlor KE, Wentworth JM, Vasanthakumar A, Gerlic M, Whitehead LW, DiRago L, Cengia L, Lane RM, Metcalf D, Vince JE, Harrison LC, Kallies A, Kile BT, Croker BA, Febbraio MA, Masters SL (2016) IL-18 Production from the NLRP1 inflammasome prevents obesity and metabolic syndrome. Cell Metab 23(1):155–164CrossRefPubMed Murphy AJ, Kraakman MJ, Kammoun HL, Dragoljevic D, Lee MK, Lawlor KE, Wentworth JM, Vasanthakumar A, Gerlic M, Whitehead LW, DiRago L, Cengia L, Lane RM, Metcalf D, Vince JE, Harrison LC, Kallies A, Kile BT, Croker BA, Febbraio MA, Masters SL (2016) IL-18 Production from the NLRP1 inflammasome prevents obesity and metabolic syndrome. Cell Metab 23(1):155–164CrossRefPubMed
12.
go back to reference Petersen AM, Penkowa M, Iversen M, Frydelund-Larsen L, Andersen JL, Mortensen J, Lange P, Pedersen BK (2007) Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung 185(3):161–171CrossRefPubMed Petersen AM, Penkowa M, Iversen M, Frydelund-Larsen L, Andersen JL, Mortensen J, Lange P, Pedersen BK (2007) Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung 185(3):161–171CrossRefPubMed
13.
go back to reference Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Mühl H, Yoon DY, Reznikov LL, Kim SH, Rubinstein M (1998) Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 63(6):658–664CrossRefPubMed Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Mühl H, Yoon DY, Reznikov LL, Kim SH, Rubinstein M (1998) Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 63(6):658–664CrossRefPubMed
14.
go back to reference Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 74(3):391–398CrossRef Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 74(3):391–398CrossRef
15.
go back to reference Herselman M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D (2008) Protein-energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients. J Ren Nutr 10(1):7–15CrossRef Herselman M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D (2008) Protein-energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients. J Ren Nutr 10(1):7–15CrossRef
16.
go back to reference Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD (2004) Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80(2):299–307CrossRefPubMed Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD (2004) Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80(2):299–307CrossRefPubMed
17.
go back to reference Kanazawa Y, Nakao T, Murai S, Okada T, Matsumoto H (2017) Diagnosis and prevalence of protein-energy wasting and its association with mortality in Japanese haemodialysis patients. Nephrology (Carlton) 22(7):541–547CrossRef Kanazawa Y, Nakao T, Murai S, Okada T, Matsumoto H (2017) Diagnosis and prevalence of protein-energy wasting and its association with mortality in Japanese haemodialysis patients. Nephrology (Carlton) 22(7):541–547CrossRef
18.
go back to reference Meuwese CL, Carrero JJ, Stenvinkel P (2011) Recent insights in inflammation-associated wasting in patients with chronic kidney disease. Contrib Nephrol 171:120–126CrossRefPubMed Meuwese CL, Carrero JJ, Stenvinkel P (2011) Recent insights in inflammation-associated wasting in patients with chronic kidney disease. Contrib Nephrol 171:120–126CrossRefPubMed
19.
go back to reference Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20(5):440–451CrossRefPubMed Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20(5):440–451CrossRefPubMed
20.
go back to reference Jankowska M, Cobo G, Lindholm B, Stenvinkel P (2017) Inflammation and protein-energy wasting in the uremic milieu. Contrib Nephrol 191:58–71CrossRefPubMed Jankowska M, Cobo G, Lindholm B, Stenvinkel P (2017) Inflammation and protein-energy wasting in the uremic milieu. Contrib Nephrol 191:58–71CrossRefPubMed
21.
go back to reference Snaedal S, Qureshi AR, Lund SH, Germanis G, Hylander B, Heimbürger O, Carrero JJ, Stenvinkel P, Bárány P (2016) Dialysis modality and nutritional status are associated with variability of inflammatory markers. Nephrol Dial Transpl 31(8):1320–1327CrossRef Snaedal S, Qureshi AR, Lund SH, Germanis G, Hylander B, Heimbürger O, Carrero JJ, Stenvinkel P, Bárány P (2016) Dialysis modality and nutritional status are associated with variability of inflammatory markers. Nephrol Dial Transpl 31(8):1320–1327CrossRef
22.
go back to reference Zhang YY, Huang J, Yang M, Gu LJ, Ji JY, Wang LJ, Yuan WJ (2015) Effect of a low-protein diet supplemented with keto-acids on autophagy and inflammation in 5/6 nephrectomized rats. Biosci Rep 35(5):e00263CrossRefPubMedPubMedCentral Zhang YY, Huang J, Yang M, Gu LJ, Ji JY, Wang LJ, Yuan WJ (2015) Effect of a low-protein diet supplemented with keto-acids on autophagy and inflammation in 5/6 nephrectomized rats. Biosci Rep 35(5):e00263CrossRefPubMedPubMedCentral
23.
go back to reference Jankowska M, Cobo G, Lindholm B, Stenvinkel P (2017) Inflammation and protein-energy wasting in the uremic milieu. Contrib Nephrol 191:58–71CrossRefPubMed Jankowska M, Cobo G, Lindholm B, Stenvinkel P (2017) Inflammation and protein-energy wasting in the uremic milieu. Contrib Nephrol 191:58–71CrossRefPubMed
24.
go back to reference Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H, Kaster MP (2017) NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun 64:367–383CrossRefPubMed Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H, Kaster MP (2017) NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun 64:367–383CrossRefPubMed
25.
go back to reference Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, Bartfai T, Conti B (2007) Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA 104(26):11097–11102CrossRefPubMed Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, Bartfai T, Conti B (2007) Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA 104(26):11097–11102CrossRefPubMed
26.
go back to reference Zorrilla EP, Conti B (2014) Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice. Brain Behav Immun 37:45–53CrossRefPubMed Zorrilla EP, Conti B (2014) Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice. Brain Behav Immun 37:45–53CrossRefPubMed
27.
go back to reference Hale MW, Spencer SJ, Conti B, Jasoni CL, Kent S, Radler ME, Reyes TM, Sominsky L (2015) Diet, behavior and immunity across the lifespan. Neurosci Biobehav Rev 58:46–62CrossRefPubMed Hale MW, Spencer SJ, Conti B, Jasoni CL, Kent S, Radler ME, Reyes TM, Sominsky L (2015) Diet, behavior and immunity across the lifespan. Neurosci Biobehav Rev 58:46–62CrossRefPubMed
28.
go back to reference Francesconi W, Sánchez-Alavez M, Berton F, Alboni S, Benatti C, Mori S, Nguyen W, Zorrilla E, Moroncini G, Tascedda F, Conti B (2016) The proinflammatory cytokine interleukin 18 regulates feeding by acting on the bed nucleus of the stria terminalis. J Neurosci 36(18):5170–5180CrossRefPubMedPubMedCentral Francesconi W, Sánchez-Alavez M, Berton F, Alboni S, Benatti C, Mori S, Nguyen W, Zorrilla E, Moroncini G, Tascedda F, Conti B (2016) The proinflammatory cytokine interleukin 18 regulates feeding by acting on the bed nucleus of the stria terminalis. J Neurosci 36(18):5170–5180CrossRefPubMedPubMedCentral
29.
go back to reference Ruperto M, Sanchez-Muniz FJ, Barril G (2016) Predictors of protein-energy wasting in haemodialysis patients: a cross-sectional study. J Hum Nutr Diet 29(1):38–47CrossRefPubMed Ruperto M, Sanchez-Muniz FJ, Barril G (2016) Predictors of protein-energy wasting in haemodialysis patients: a cross-sectional study. J Hum Nutr Diet 29(1):38–47CrossRefPubMed
30.
go back to reference Marcelli D, Wabel P, Wieskotten S, Ciotola A, Grassmann A, Di Benedetto A, Canaud B (2015) Physical methods for evaluating the nutrition status of hemodialysis patients. J Nephrol 28(5):523–530CrossRefPubMed Marcelli D, Wabel P, Wieskotten S, Ciotola A, Grassmann A, Di Benedetto A, Canaud B (2015) Physical methods for evaluating the nutrition status of hemodialysis patients. J Nephrol 28(5):523–530CrossRefPubMed
31.
go back to reference Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K (2008) Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 88(6):1485–1494CrossRefPubMedPubMedCentral Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K (2008) Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 88(6):1485–1494CrossRefPubMedPubMedCentral
32.
go back to reference Ahmad R, Thomas R, Kochumon S, Sindus S (2017) Increased adipose tissue expression of IL-18R and its ligand IL-18 associates with inflammation and insulin resistance in obesity. Immun Inflamm Dis 5(3):318–335CrossRefPubMedPubMedCentral Ahmad R, Thomas R, Kochumon S, Sindus S (2017) Increased adipose tissue expression of IL-18R and its ligand IL-18 associates with inflammation and insulin resistance in obesity. Immun Inflamm Dis 5(3):318–335CrossRefPubMedPubMedCentral
33.
go back to reference Yasui S, Shirai Y, Tanimura M, Matsuura S, Saito Y, Miyata K, Ishikawa E, Miki C, Hamada Y (2016) Prevalence of protein-energy wasting (PEW) and evaluation of diagnostic criteria in Japanese maintenance hemodialysis patients. Asia Pac J Clin Nutr 25(2):292–299PubMed Yasui S, Shirai Y, Tanimura M, Matsuura S, Saito Y, Miyata K, Ishikawa E, Miki C, Hamada Y (2016) Prevalence of protein-energy wasting (PEW) and evaluation of diagnostic criteria in Japanese maintenance hemodialysis patients. Asia Pac J Clin Nutr 25(2):292–299PubMed
Metadata
Title
Association of serum IL-18 with protein-energy wasting in end-stage renal disease patients on haemodialysis
Authors
Xiao Bi
Mingzi Chu
Honglan Ai
Chun Hu
Wei Ding
Publication date
01-07-2019
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 7/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02167-5

Other articles of this Issue 7/2019

International Urology and Nephrology 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.